Search | HMA-EMA Catalogues of real-world data sources and studies

Results(4699)

Nivel Primary Care Database

Netherlands

First published:

01/02/2024

Last updated 22/06/2026

Data source

Human

Primary care medical records

Record completeness: 100%

Compare Compare

VAC4EU Postauthorisation Effectiveness Study of BIMERVAX® Vaccine in Europe

Spain

EU PAS number:

EUPAS1000000337

First published:

21/10/2024

Last updated 22/06/2026

Study Planned

VAC4EU Postauthorisation Safety Study of BIMERVAX® Vaccine in Europe

Spain

EU PAS number:

EUPAS1000000321

First published:

21/10/2024

Last updated 22/06/2026

Study Planned

Vedolizumab-4081: Infection Outcomes among Advanced Therapy-naive Older Adult US Patients With UC/CD Initiating ENTYVIO, TNF-alpha Inhibitors, or Ustekinumab: A Retrospective Observational Matched-Cohort Study Using Medicare Claims Data, 2016-2025

United States

EU PAS number:

EUPAS1000000767

First published:

17/12/2025

Last updated 22/06/2026

Study Planned

Observational Cohort Study of Safety of Etrasimod During Pregnancy in US Claims Databases (C5041042)

United States

EU PAS number:

EUPAS1000000832

First published:

19/06/2026

Last updated 19/06/2026

Study Planned

A Post-Marketing Safety Study to Evaluate the Safety of VELSIPITY® (Etrasimod) Exposure During Pregnancy (C5041043)

Canada

United States

EU PAS number:

EUPAS1000000672

First published:

03/09/2025

Last updated 19/06/2026

Study Ongoing

Observational study to assess effectiveness of ROTATEQ® against acute gastroenteritis (AGE) due to rotavirus (regardless of type) and by type in China

China

EU PAS number:

EUPAS1000000734

First published:

23/09/2025

Last updated 19/06/2026

Study Finalised

Real-world experience of children with growth hormone deficiency who switched from daily growth hormone to the Long-Acting Growth Hormone Somatrogon

Czechia

Israel

EU PAS number:

EUPAS1000000829

First published:

07/01/2026

Last updated 19/06/2026

Study Ongoing

Utilization and Effectiveness of PCSK9 Inhibitors in Familial Hypercholesterolemia

Canada

EU PAS number:

EUPAS1000000387

First published:

03/12/2024

Last updated 17/06/2026

Study Finalised

Long-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease

Canada

EU PAS number:

EUPAS1000000325

First published:

18/10/2024

Last updated 17/06/2026

Study Finalised

Isotretinoin, Contraception, and Pregnancy Outcomes

Canada

EU PAS number:

EUPAS1000000927

First published:

26/03/2026

Last updated 17/06/2026

Study Ongoing

BIOKSAN

Spain

First published:

17/06/2026

Last updated 17/06/2026

Institution Laboratory/Research/Testing facility

Canadian Network for Observational Drug Effect Studies (CNODES)

Canada

First published:

17/06/2026

Last updated 17/06/2026

Network

Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

United States

EU PAS number:

EUPAS45952

First published:

24/02/2022

Last updated 17/06/2026

Study Ongoing

Clinical burden comparison among elderly hospitalized patients for COVID-19, RSV, and influenza: a French study on inpatients HER (OMIP Study)

France

EU PAS number:

EUPAS1000000275

First published:

27/03/2025

Last updated 17/06/2026

Study Ongoing

Post-marketing Safety Study of mRNA-1283 in the United States

United States

EU PAS number:

EUPAS1000000971

First published:

08/04/2026

Last updated 16/06/2026

Study Ongoing

Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)

United States

EU PAS number:

EUPAS1000000441

First published:

21/02/2025

Last updated 16/06/2026

Study Ongoing

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation – "BOSTON EVOLUTION"

Belgium

Spain

United States

EU PAS number:

EUPAS1000001016

First published:

16/06/2026

Last updated 16/06/2026

Study Finalised

DARWIN EU® – Benzodiazepine use during pregnancy: a descriptive study characterising exposure, pregnancy loss, and covariates to inform future safety studies

Norway

Spain

EU PAS number:

EUPAS1000000536

First published:

02/04/2025

Last updated 15/06/2026

Study Ongoing

Clinical Data Warehouse of the Bordeaux University Hospital

France

First published:

01/02/2024

Last updated 12/06/2026

Data source

Human

Other

Record completeness: 94%

Compare Compare

Belzutifan special drug use results survey in radically unresectable or metastatic renal cell carcinoma: a postauthorization safety study (PASS) (MK-6482-045)

Japan

EU PAS number:

EUPAS1000000880

First published:

20/02/2026

Last updated 12/06/2026

Study Ongoing

Ustekinumab and Risk of Small for Gestational Age in Inflammatory Bowel Disease Pregnancies: Data from the DUMBO Registry

Spain

EU PAS number:

EUPAS1000001012

First published:

02/06/2026

Last updated 11/06/2026

Study Finalised

Retrospective Multi-center Study of the Burden of MBL-producing Enterobacterales in Critically Ill Adults in Spain

Spain

EU PAS number:

EUPAS1000000733

First published:

05/01/2026

Last updated 11/06/2026

Study Ongoing

DARWIN EU® - Azathioprine - user characteristics

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000322

First published:

26/09/2024

Last updated 11/06/2026

Study Finalised

Effectiveness of LORlatinib as a Real-World, first-line treatment in ALK-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients in Italy(LOR-ALK).

Italy

EU PAS number:

EUPAS1000000856

First published:

10/06/2026

Last updated 10/06/2026

Study Planned

A Post-Authorisation Safety Study to Evaluate the Safety of Marstacimab Among Patients with Haemophilia A or B using Real-World Data in Haemophilia Registers

United Kingdom

United States

EU PAS number:

EUPAS1000000947

First published:

10/06/2026

Last updated 10/06/2026

Study Planned

Real World Use, Effectiveness and Safety of Romosozumab among Osteoporosis Patients in Guangdong China (20250009)

China

EU PAS number:

EUPAS1000000758

First published:

16/10/2025

Last updated 10/06/2026

Study Ongoing

A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)

France

EU PAS number:

EUPAS1000000759

First published:

07/10/2025

Last updated 10/06/2026

Study Ongoing

TAK-755-4007: A Post-Authorization Safety Study (PASS) to Further Evaluate Real-World Safety in Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated with Adzynma

Austria

France

Germany

Italy

Poland

Spain

Switzerland

United Kingdom

EU PAS number:

EUPAS1000000870

First published:

14/01/2026

Last updated 10/06/2026

Study Ongoing

Evaluating the Effectiveness of Eliquis® Additional Risk Minimization Measures in Kingdom of Saudi Arabia.

Saudi Arabia

EU PAS number:

EUPAS1000000270

First published:

21/05/2025

Last updated 10/06/2026

Study Ongoing

The Swedish Multiple Sclerosis Registry

Sweden

First published:

09/06/2026

Last updated 09/06/2026

Data source

Human

Disease registry

Record completeness: 90%

Compare Compare

Oslo University Hospital Clinical Data Warehouse

Norway

First published:

30/08/2024

Last updated 09/06/2026

Data source

Human

Hospital discharge records Hospital inpatient records Hospital outpatient visit records Other

Record completeness: 91%

Compare Compare

The European HBV Registry - A joint initiative of TherVacB and DZIF

Germany

Italy

Spain

First published:

01/02/2024

Last updated 09/06/2026

Data source

Human

Disease registry

Record completeness: 87%

Compare Compare

Pregnancy Exposures and Outcomes in Women with Inflammatory Bowel Disease Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States

United States

EU PAS number:

EUPAS1000000283

First published:

06/08/2024

Last updated 09/06/2026

Study Ongoing

DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study Update

Croatia

Denmark

Finland

Germany

Spain

Sweden

EU PAS number:

EUPAS1000000998

First published:

08/05/2026

Last updated 09/06/2026

Study Ongoing

DARWIN EU® - Characteristics of individuals with acute graft vs. host disease with intestinal involvement

France

Germany

Spain

EU PAS number:

EUPAS1000000878

First published:

17/12/2025

Last updated 09/06/2026

Study Ongoing

The European HBV Registry: A joint initiative of TherVacB and DZIF (HBV Registry)

Germany

Italy

Spain

United Kingdom

EU PAS number:

EUPAS42767

First published:

03/09/2021

Last updated 09/06/2026

Study Ongoing

TARGET-EU: Feasibility assessment based on the Data Quality Framework for EU medicines regulation.

Belgium

Denmark

Finland

Greece

Italy

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000791

First published:

31/10/2025

Last updated 08/06/2026

Study Finalised

The Valencia Health System Integrated Database

Spain

First published:

01/02/2024

Last updated 08/06/2026

Data source

Human

Hospital outpatient visit records Other Primary care medical records Registration with healthcare system

Record completeness: 97%

Compare Compare

Pan European Prospective Observational Study of Fremanezumab effectiveness in patients with chronic or episodic migraine in the Real-World: PEARL study

Czechia

Denmark

Finland

Greece

Italy

Norway

Portugal

Spain

Sweden

Switzerland

United Kingdom

EU PAS number:

EUPAS35111

First published:

07/05/2020

Last updated 05/06/2026

Study Finalised

Search all content

Results(4699)